In 2021, President Biden directed the FDA to lower prices on generic prescriptions and to import medication from Canada. Which of the following best summarizes what factors went into the president’s cost-benefit analysis for this market?(1 point)

Question

Responses

The president considered the cost for prescriptions in Mexico, the cost for prescriptions in Canada, and the benefits for Americans purchasing from both countries.
The president considered the cost for prescriptions in Mexico, the cost for prescriptions in Canada, and the benefits for Americans purchasing from both countries.

The president considered the cost for prescriptions in the U.S., the cost for prescriptions in Canada, and the benefits for Americans traveling across the border to see a physician.
The president considered the cost for prescriptions in the U.S., the cost for prescriptions in Canada, and the benefits for Americans traveling across the border to see a physician.

The president considered the cost for medical care in the U.S., the cost for prescriptions in Canada, and the benefits for Americans purchasing medicine from overseas.
The president considered the cost for medical care in the U.S., the cost for prescriptions in Canada, and the benefits for Americans purchasing medicine from overseas.

The president considered the cost for prescriptions in the U.S., the cost for prescriptions in Canada, and the benefits for Americans purchasing from both countries.

Answer 1

The option that best summarizes the factors that went into President Biden’s cost-benefit analysis for the market is:

The president considered the cost for prescriptions in the U.S., the cost for prescriptions in Canada, and the benefits for Americans purchasing from both countries.